LILA vs ZD

LILA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. The company is dangerously over-leveraged with a Debt/Equity ratio of 8.32, vastly exceeding the sector average of 0.90. While the stock has seen a 1-year price recovery and maintains a low Price/Sales ratio of 0.37, these are overshadowed by negative profit margins (-13.76%) and a disastrous ROE of -41.72%. The disconnect between the analyst 'Buy' recommendation and the deterministic health scores suggests a speculative bet on restructuring rather than a value-based investment.

ZD presents a contradictory profile with a stable Piotroski F-Score of 4/9 but severe valuation discrepancies. While the stock has seen a strong 1-year recovery (+54.2%), it trades significantly above its Graham Number ($34.39) and far exceeds its growth-based intrinsic value ($8.05). The massive YoY earnings collapse (-99.70%) is a critical concern, though a low Forward P/E of 8.21 suggests analysts expect a sharp rebound. Overall, the company possesses strong gross margins but lacks the growth and technical momentum to justify a bullish rating at current levels.